Defining the early-stage OA patient: the EsSKOA initiative with Dr Armaghan Mahmoudian

What does it actually mean to have 'early-stage' osteoarthritis, and does catching it sooner really make a difference? On this week's episode of Joint Action, learn more about early-stage knee osteoarthritis, how it's defined, and why the EsSKOA initiative is changing the way we identify and understand the condition in its earliest phases.

Dr. Armaghan Mahmoudian is an Assistant Professor of Movement Sciences and Health at the University of West Florida, where she teaches anatomy and physiology, biomechanics, and research methods, and co-directs the biomechanics and motor learning laboratory. As a clinician-scientist, her research focuses on understanding disease mechanisms and their impact on function and quality of life, with a particular interest in personalised medicine and disease prevention in an ageing population.

RESOURCES

• EsSKOA Initiative
• Journal article Reframing early-stage symptomatic knee osteoarthritis (EsSKOA): A strategic lens for trial design

CONNECT WITH US

• Naia Health: https://www.naiahealth.com.au/st-leonards-hub
• Join one of our trials https://www.osteoarthritisresearch.com.au/current-trials
• Instagram: @ProfDavidHunter
• Twitter: @ProfDavidHunter @jointactionorg
• Email: hello@jointaction.info
• Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.